Rimonabant
0.0
More buying options:
Rimonabant is a popular weight loss ingredient as it is included as the primary dietary ingredient in one of the most popular prescription-only weight loss products, Acomplia. Developed and approved for the European market in the summer of 2006, Rimonabant is the primary ingredient in Acomplia that is intended to provide individuals suffering with obesity enhanced weight loss support.
How Does Rimonabant Work?
Rimonabant is a chemically created agent included in Acomplia that has not yet been approved for consumption in the United States. With its recent development in the past few years, Rimonabant is classified as a “Cannabinoid-1 Receptor Blockers (CB1).” To provide consumers with weight loss support, Rimonabant selectively blocks CB1 receptors in the brain and peripheral organs. With this process, the brain is able to turn off its hunger receptors, allowing dieters to reduce their intake of food and calories without feeling cravings, discomfort, or temptation.
As the CB1 receptors in the brain are responsible for the body’s glucose and metabolism, Rimonabant’s effect on the brain is intended to help provide dieters with safe, strong, and effective dietary support.
Rimonabant and Acomplia
Rimonabant is most popularly found only in Acomplia. Acomplia is only intended to help individuals who are suffering with clinical obesity, and should be used only in conjunction with a plan of both diet and exercise. By taking Acomplia with Rimonabant, dieters suffering with obesity, Type 2 diabetes, and abnormal fat levels in the blood should experience an array of health and physical improvements over time. As Acomplia helps reduce consumers’ weight and body fat, Acomplia with Rimonabant may also help reduce the risks associated with cardiovascular disease, in addition to helping dieters prevent a myriad of other diseases and problems associated with obesity and excess body weight.
Pros of Rimonabant
- Dieters taking Rimonabant should experience effective weight loss support with minimal side effects
- Rimonabant has been shown to help reduce serious risks associated with obesity
- Acomplia with Rimonabant has also been shown to help some individuals quit smoking
- Acomplia with Rimonabant has been subjected to an array of clinical studies and trials; therefore, the effectiveness of Acomplia has been proven to be generally effective
- Some health insurance companies may cover the cost of Acomplia
Cons of Rimonabant
- Acomplia with Rimonabant is not yet approved for consumption in the United States
- Rimonabant has not yet been approved by the Food and Drug Administration
- Dieters who are clinically diagnosed as morbidly obese tend to be the only individuals who are qualified to take Acomplia with Rimonabant
- The long term side effects / implications of Rimonabant are generally unknown, as Rimonabant is still a fairly new ingredient / compound
- Acomplia with Rimonabant is only available with a prescription
- Rimonabant in Acomplia may cause various side effects, some of which may include:
- Vomiting
- Nausea
- Stomach pain / discomfort
- Anxiety
- Mental / mood disorders
- Panic attacks
